Shared and Usable Data From Phase 1 Oncology Trials-An Unmet Need

JAMA Oncol. 2020 Jul 1;6(7):980-981. doi: 10.1001/jamaoncol.2020.0144.

Authors

Andrea Arfè¹, Steffen Ventz¹, Lorenzo Trippa¹

Affiliation

¹ Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

PMID: 32496530
DOI: 10.1001/jamaoncol.2020.0144

No abstract available

MeSH terms

Clinical Trials, Phase I as Topic*
Humans
Immune Checkpoint Inhibitors / adverse effects
Immune Checkpoint Inhibitors / therapeutic use
Information Dissemination*
Neoplasms / drug therapy*
Research Design

Substances

Immune Checkpoint Inhibitors